Abbott's projection of its Q2 2024 adjusted EPS aligns with the higher end of analyst consensus estimates, indicating a positive outlook on its financial performance. This alignment with expectations suggests confidence in the company's operational efficiency and profitability, likely leading to a positive investor sentiment and potential upward movement in its stock price in the short term.